Our website uses cookies to improve and personalise your experience and to display advertisements(if any). Our website may also include third-party cookies like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Africa’s first mRNA vaccine technology transfer hub gets to work

Africa’s first mRNA vaccine technology transfer hub gets to work

THE World Health Organisation and the COVID Vaccines Global Access (COVAX) initiative announced in mid-2021 that they were working with a consortium to establish the first COVID messenger RNA (mRNA) vaccine technology transfer hub on the African continent, in South Africa. The Conversation Africa’s Natasha Joseph spoke with Petro Terblanche, Afrigen’s managing director and a professor at South Africa’s North-West University, about what this work entails – and what it will mean for the continent. PETRO TERBLANCHE, Professor, Business Development; Managing Director, Afrigen Biologics, North-West University What is a technology transfer hub? The technology transfer model is designed to create…
Read More
Africa to make own COVID-19 vaccines

Africa to make own COVID-19 vaccines

THE World Health Organization (WHO) is setting up a technology transfer hub for producing mRNA COVID-19 vaccines in South Africa, which could start manufacturing doses in 9 to 12 months. WHO director-general Tedros Adhanom Ghebreyesus made the announcement aimed at boosting access to vaccines across the African continent, where cases and deaths had increased by almost 40% over the past week. "Today I am delighted to announce that WHO is in discussions with a consortium of companies and institutions to establish a technology transfer hub in South Africa," Tedros told a news conference. "The consortium involves a company Afrigen Biologics…
Read More